Immunogenicity and Safety of DTaP-IPV-HB-PRP~T Combined Vaccine Given at 3, 5, and 12 Monhs of Age Concomitantly or Sequentially 4CMenB Vaccine in Italian Infants
Latest Information Update: 08 May 2024
At a glance
- Drugs Hib-DTaP-hepatitis B-poliovirus vaccine (Primary) ; Meningococcal vaccine group B OMV Novartis (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate
- Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
- Focus Pharmacodynamics
- Sponsors Sanofi Pasteur
- 08 May 2024 This trial has been completed in Finland, according to European Clinical Trials Database record.
- 07 Aug 2020 New trial record